Informations techniques
Exploitant
Laboratoires PROSTRAKAN PHARMA
Présentation
DROLEPTAN 2,5 mg/ 1ml, solution injectable (IV) B/10 - CIP 561 122-8
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
9J69Nk3BWZJCrpYZ